Want to join the conversation?
All three of $ADS's operating segment achieved double digit growth on a constant currency basis in 3Q15. Organic revenue growth has continued to aid double digit rate. Epsilon saw a strong revenue growth during the quarter, primarily due to the Conversant acquisition.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?